Matches in SemOpenAlex for { <https://semopenalex.org/work/W1917210901> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W1917210901 endingPage "43" @default.
- W1917210901 startingPage "1235" @default.
- W1917210901 abstract "The alpha-2 adrenoceptor subtype and its signal transduction pathway mediating vascular relaxation in rats were studied in vitro using rings of superior mesenteric arteries. Removal of endothelium or incubation with NG-nitro-L-arginine completely blocked relaxant responses to UK14,304, suggesting endothelium-derived nitric oxide mediates relaxation. The order of potency for full (F) or partial (P) agonists causing relaxation was guanabenz (P) > UK14,304 (F) > clonidine (P) > epinephrine (F) > norepinephrine (F). Affinities (Ka) of alpha-2 adrenoceptor subtype-selective drugs for blocking relaxation were obtained in side-by-side experiments comparing rat mesenteric arteries with pig coronary arteries. Relaxation of pig coronary arteries is known to be mediated by the alpha-2A adrenoceptor subtype. Ka values in nM for rauwolscine (19), WB-4101 (265), SKF-104078 (197), spiroxatrine (128), and prazosin (1531) for blocking relaxation in rat arteries were consistent with their affinities for binding at the alpha-2D adrenoceptor subtype. Ka values for rauwolscine and WB-4101, drugs distinguishing the alpha-2D from the alpha-2A adrenoceptor subtype, were significantly higher in blocking relaxation of rat arteries compared with pig arteries, suggesting the alpha-2D adrenoceptor subtype mediates NO-induced relaxation in rat arteries. We used forskolin to oppose alpha-2 adrenoceptor-mediated inhibition of cAMP formation by directly stimulating cAMP formation in endothelium. Forskolin did not affect the relaxant response to UK14,304, suggesting that cAMP is not involved in the coupling of alpha-2 adrenoceptors to nitric oxide-induced vascular relaxation." @default.
- W1917210901 created "2016-06-24" @default.
- W1917210901 creator A5035314160 @default.
- W1917210901 creator A5050035885 @default.
- W1917210901 creator A5075547834 @default.
- W1917210901 date "1996-09-01" @default.
- W1917210901 modified "2023-10-10" @default.
- W1917210901 title "Alpha-2 adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats." @default.
- W1917210901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8819507" @default.
- W1917210901 hasPublicationYear "1996" @default.
- W1917210901 type Work @default.
- W1917210901 sameAs 1917210901 @default.
- W1917210901 citedByCount "25" @default.
- W1917210901 countsByYear W19172109012012 @default.
- W1917210901 countsByYear W19172109012015 @default.
- W1917210901 countsByYear W19172109012016 @default.
- W1917210901 countsByYear W19172109012017 @default.
- W1917210901 crossrefType "journal-article" @default.
- W1917210901 hasAuthorship W1917210901A5035314160 @default.
- W1917210901 hasAuthorship W1917210901A5050035885 @default.
- W1917210901 hasAuthorship W1917210901A5075547834 @default.
- W1917210901 hasConcept C126322002 @default.
- W1917210901 hasConcept C13348194 @default.
- W1917210901 hasConcept C134018914 @default.
- W1917210901 hasConcept C170493617 @default.
- W1917210901 hasConcept C185592680 @default.
- W1917210901 hasConcept C2776504411 @default.
- W1917210901 hasConcept C2776820930 @default.
- W1917210901 hasConcept C2776885963 @default.
- W1917210901 hasConcept C2776992346 @default.
- W1917210901 hasConcept C2777663904 @default.
- W1917210901 hasConcept C2779276759 @default.
- W1917210901 hasConcept C2779395532 @default.
- W1917210901 hasConcept C2780648677 @default.
- W1917210901 hasConcept C2780771799 @default.
- W1917210901 hasConcept C2992686903 @default.
- W1917210901 hasConcept C40465926 @default.
- W1917210901 hasConcept C519581460 @default.
- W1917210901 hasConcept C71924100 @default.
- W1917210901 hasConceptScore W1917210901C126322002 @default.
- W1917210901 hasConceptScore W1917210901C13348194 @default.
- W1917210901 hasConceptScore W1917210901C134018914 @default.
- W1917210901 hasConceptScore W1917210901C170493617 @default.
- W1917210901 hasConceptScore W1917210901C185592680 @default.
- W1917210901 hasConceptScore W1917210901C2776504411 @default.
- W1917210901 hasConceptScore W1917210901C2776820930 @default.
- W1917210901 hasConceptScore W1917210901C2776885963 @default.
- W1917210901 hasConceptScore W1917210901C2776992346 @default.
- W1917210901 hasConceptScore W1917210901C2777663904 @default.
- W1917210901 hasConceptScore W1917210901C2779276759 @default.
- W1917210901 hasConceptScore W1917210901C2779395532 @default.
- W1917210901 hasConceptScore W1917210901C2780648677 @default.
- W1917210901 hasConceptScore W1917210901C2780771799 @default.
- W1917210901 hasConceptScore W1917210901C2992686903 @default.
- W1917210901 hasConceptScore W1917210901C40465926 @default.
- W1917210901 hasConceptScore W1917210901C519581460 @default.
- W1917210901 hasConceptScore W1917210901C71924100 @default.
- W1917210901 hasIssue "3" @default.
- W1917210901 hasLocation W19172109011 @default.
- W1917210901 hasOpenAccess W1917210901 @default.
- W1917210901 hasPrimaryLocation W19172109011 @default.
- W1917210901 hasRelatedWork W1267193224 @default.
- W1917210901 hasRelatedWork W1917210901 @default.
- W1917210901 hasRelatedWork W1966146990 @default.
- W1917210901 hasRelatedWork W1978919671 @default.
- W1917210901 hasRelatedWork W1983321239 @default.
- W1917210901 hasRelatedWork W2008170529 @default.
- W1917210901 hasRelatedWork W2021145278 @default.
- W1917210901 hasRelatedWork W2140914145 @default.
- W1917210901 hasRelatedWork W2276635401 @default.
- W1917210901 hasRelatedWork W2466340235 @default.
- W1917210901 hasVolume "278" @default.
- W1917210901 isParatext "false" @default.
- W1917210901 isRetracted "false" @default.
- W1917210901 magId "1917210901" @default.
- W1917210901 workType "article" @default.